|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.815
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.690
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.626
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.563
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.456
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.399
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.362
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.356
|
Human |
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.347
|
Human |
|
|
muscle contraction
|
GO:0006936 |
101 |
0.322
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.318
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.313
|
Human |
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.311
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.305
|
Human |
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.301
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.298
|
Human |
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.265
|
|
|
|
fear response
|
GO:0042596 |
33 |
0.265
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.252
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.237
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.235
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.229
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.227
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.220
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.220
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.205
|
Human |
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.201
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.199
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.196
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.195
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.194
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.193
|
|
|
|
neutrophil activation involved in immune response
|
GO:0002283 |
8 |
0.192
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.188
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.188
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.183
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.181
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.178
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.177
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.172
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.171
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.167
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.165
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.164
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.164
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.161
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.158
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.157
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.152
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.151
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.149
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.147
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.142
|
Human |
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.140
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.136
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.135
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.133
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.128
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.127
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.125
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.124
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.122
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.122
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.121
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.119
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.116
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.115
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.113
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.113
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.111
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.110
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.109
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.109
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.108
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.108
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.107
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.102
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.102
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.101
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.100
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.100
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.099
|
Human |
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.097
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.097
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.096
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.095
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.095
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.095
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.094
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.094
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.093
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.092
|
Human |
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.092
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.090
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.090
|
|
|
|
endothelial cell apoptotic process
|
GO:0072577 |
9 |
0.089
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.089
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.088
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.087
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.087
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.087
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.087
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.087
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.086
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.086
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.086
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.086
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.086
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.085
|
Human |
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.085
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.084
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.084
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.084
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.083
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.083
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.082
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.082
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.082
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.081
|
Human |
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.081
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.080
|
Human |
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.080
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.080
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.080
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.079
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.079
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.078
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.078
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.078
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.077
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.077
|
|
|
|
regulation of endothelial cell apoptotic process
|
GO:2000351 |
9 |
0.076
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.076
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.075
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.075
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.075
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.075
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.074
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.073
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.072
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.072
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.072
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.071
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.070
|
|
|
|
regulation of mast cell activation
|
GO:0033003 |
21 |
0.070
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.070
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.070
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.069
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.069
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.069
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.069
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.068
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.068
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.067
|
|
|
|
fourth ventricle development
|
GO:0021592 |
2 |
0.067
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.067
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.067
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.066
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.065
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.065
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.064
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.064
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.064
|
Human |
|
|
lipid transport
|
GO:0006869 |
98 |
0.063
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.063
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.063
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.063
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.063
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.062
|
Human |
|
|
gonad development
|
GO:0008406 |
141 |
0.062
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.062
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.062
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.062
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.061
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.061
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.061
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.061
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.060
|
|
|
|
serotonin secretion involved in inflammatory response
|
GO:0002442 |
4 |
0.060
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.059
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.059
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.059
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.059
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.058
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.058
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.058
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.057
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.057
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.057
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.056
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.056
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.056
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.056
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.056
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.056
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.055
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.055
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.055
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.055
|
|
|
|
neutrophil activation
|
GO:0042119 |
9 |
0.054
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.054
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.054
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.054
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.053
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.053
|
Human |
|
|
membrane organization
|
GO:0061024 |
245 |
0.053
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.053
|
|
|
|
dopamine catabolic process
|
GO:0042420 |
4 |
0.053
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.053
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.053
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.052
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.052
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.052
|
Human |
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.052
|
Human |
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.052
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.052
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.052
|
|
|
|
memory
|
GO:0007613 |
58 |
0.052
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.052
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.052
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.052
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.051
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.051
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.051
|
Human |
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.051
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.051
|
Human |
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.051
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.050
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.050
|
Human |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.050
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.050
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.050
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.050
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.049
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.049
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.049
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.049
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.049
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.048
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.048
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.048
|
|
|
|
negative regulation of endothelial cell apoptotic process
|
GO:2000352 |
7 |
0.048
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.048
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.048
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.047
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.047
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.047
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.047
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.047
|
Human |
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.047
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.047
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.046
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.046
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.046
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.046
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.046
|
Human |
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.046
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.045
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.045
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.045
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.045
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.044
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.044
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.044
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.043
|
Human |
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.043
|
Human |
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.043
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.043
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.043
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.042
|
|
|
|
granulocyte migration
|
GO:0097530 |
43 |
0.042
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.042
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.042
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.042
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.042
|
|
|
|
vascular smooth muscle cell differentiation
|
GO:0035886 |
11 |
0.042
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.042
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.041
|
Human |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.041
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.041
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.041
|
|
|
|
response to glucagon
|
GO:0033762 |
3 |
0.041
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.041
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.040
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.040
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.040
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.040
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.039
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.039
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.039
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.039
|
Human |
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.039
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.039
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.039
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.039
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.039
|
|
|
|
activation of mapkkk activity
|
GO:0000185 |
1 |
0.039
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.039
|
|
|
|
establishment of t cell polarity
|
GO:0001768 |
2 |
0.039
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.038
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.038
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.038
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.038
|
Human |
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.038
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.038
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.038
|
|
|
|
regulation of smooth muscle contraction
|
GO:0006940 |
22 |
0.038
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.038
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.037
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.037
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.037
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.037
|
Human |
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.037
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.037
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.037
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.037
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.037
|
Human |
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.036
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.036
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.036
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.036
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.036
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.036
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.035
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.035
|
Human |
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.035
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.035
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.035
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.035
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.035
|
|
|
|
serotonin production involved in inflammatory response
|
GO:0002351 |
4 |
0.035
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.035
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.035
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.035
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.034
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.034
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.034
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.034
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.034
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.034
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.034
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.034
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.034
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.033
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.033
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.033
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
29 |
0.033
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.033
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.033
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.033
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.033
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.033
|
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.033
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.032
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.032
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.032
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.032
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.032
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.032
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.032
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.032
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.032
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.032
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.032
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.032
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.032
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.032
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.031
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.031
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.031
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.031
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.031
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.031
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.031
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
27 |
0.031
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.030
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.030
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.030
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.030
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.030
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.030
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.030
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.029
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.029
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.029
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.029
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.029
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.029
|
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.029
|
|
|
|
production of molecular mediator involved in inflammatory response
|
GO:0002532 |
21 |
0.029
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.029
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.029
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.029
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.029
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.028
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.028
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.028
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.028
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.028
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.028
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.028
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.028
|
Human |
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.028
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.028
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.028
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.028
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.028
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.027
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.027
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.027
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.027
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.027
|
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.027
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.027
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.027
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.027
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.027
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.027
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.027
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.027
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.026
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.026
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.026
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.026
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.026
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.026
|
|
|
|
behavioral response to ethanol
|
GO:0048149 |
8 |
0.026
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.026
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.026
|
Human |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.026
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.026
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.026
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.026
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.026
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.026
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.025
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.025
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.025
|
Human |
|
|
insulin like growth factor receptor signaling pathway
|
GO:0048009 |
21 |
0.025
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.025
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.025
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.025
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.025
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.025
|
|
|
|
regulation of acetylcholine secretion neurotransmission
|
GO:0014056 |
2 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.025
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
7 |
0.024
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.024
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.024
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.024
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.024
|
|
|
|
positive regulation of calcium ion transport into cytosol
|
GO:0010524 |
9 |
0.024
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.024
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.024
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.024
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.024
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.024
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.024
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.024
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.023
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902042 |
11 |
0.023
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.023
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.023
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.023
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.023
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.023
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.023
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.023
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.023
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.023
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.023
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.023
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.023
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.023
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.023
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.023
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.023
|
|
|
|
regulation of type iia hypersensitivity
|
GO:0001796 |
4 |
0.023
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.022
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.022
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.022
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.022
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.022
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.022
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.022
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.022
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.022
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.022
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.022
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.022
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.022
|
|
